Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease

David A. Antonetti, Alistair J. Barber, Sarah K. Bronson, Willard M. Freeman, Thomas W. Gardner, Leonard S. Jefferson, Mark Kester, Scot R. Kimball, J. Kyle Krady, Kathryn F. LaNoue, Christopher C. Norbury, Patrick G. Quinn, Lakshman Sandirasegarane, Ian A. Simpson

Research output: Contribution to journalReview article

483 Citations (Scopus)

Abstract

Diabetic retinopathy remains a frightening prospect to patients and frustrates physicians. Destruction of damaged retina by photocoagulation remains the primary treatment nearly 50 years after its introduction. The diabetes pandemic requires new approaches to understand the pathophysiology and improve the detection, prevention, and treatment of retinopathy. This perspective considers how the unique anatomy and physiology of the retina may predispose it to the metabolic stresses of diabetes. The roles of neural retinal alterations and impaired retinal insulin action in the pathogenesis of early retinopathy and the mechanisms of vision loss are emphasized. Potential means to overcome limitations of current animal models and diagnostic testing are also presented with the goal of accelerating therapies to manage retinopathy in the face of ongoing diabetes.

Original languageEnglish (US)
Pages (from-to)2401-2411
Number of pages11
JournalDiabetes
Volume55
Issue number9
DOIs
StatePublished - Sep 1 2006

Fingerprint

Diabetic Retinopathy
Glucose
Retina
Physiological Stress
Light Coagulation
Pandemics
Anatomy
Therapeutics
Animal Models
Insulin
Physicians

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Antonetti, David A. ; Barber, Alistair J. ; Bronson, Sarah K. ; Freeman, Willard M. ; Gardner, Thomas W. ; Jefferson, Leonard S. ; Kester, Mark ; Kimball, Scot R. ; Krady, J. Kyle ; LaNoue, Kathryn F. ; Norbury, Christopher C. ; Quinn, Patrick G. ; Sandirasegarane, Lakshman ; Simpson, Ian A. / Diabetic retinopathy : Seeing beyond glucose-induced microvascular disease. In: Diabetes. 2006 ; Vol. 55, No. 9. pp. 2401-2411.
@article{c392eb51498240aa810d39d38418e308,
title = "Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease",
abstract = "Diabetic retinopathy remains a frightening prospect to patients and frustrates physicians. Destruction of damaged retina by photocoagulation remains the primary treatment nearly 50 years after its introduction. The diabetes pandemic requires new approaches to understand the pathophysiology and improve the detection, prevention, and treatment of retinopathy. This perspective considers how the unique anatomy and physiology of the retina may predispose it to the metabolic stresses of diabetes. The roles of neural retinal alterations and impaired retinal insulin action in the pathogenesis of early retinopathy and the mechanisms of vision loss are emphasized. Potential means to overcome limitations of current animal models and diagnostic testing are also presented with the goal of accelerating therapies to manage retinopathy in the face of ongoing diabetes.",
author = "Antonetti, {David A.} and Barber, {Alistair J.} and Bronson, {Sarah K.} and Freeman, {Willard M.} and Gardner, {Thomas W.} and Jefferson, {Leonard S.} and Mark Kester and Kimball, {Scot R.} and Krady, {J. Kyle} and LaNoue, {Kathryn F.} and Norbury, {Christopher C.} and Quinn, {Patrick G.} and Lakshman Sandirasegarane and Simpson, {Ian A.}",
year = "2006",
month = "9",
day = "1",
doi = "10.2337/db05-1635",
language = "English (US)",
volume = "55",
pages = "2401--2411",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "9",

}

Antonetti, DA, Barber, AJ, Bronson, SK, Freeman, WM, Gardner, TW, Jefferson, LS, Kester, M, Kimball, SR, Krady, JK, LaNoue, KF, Norbury, CC, Quinn, PG, Sandirasegarane, L & Simpson, IA 2006, 'Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease', Diabetes, vol. 55, no. 9, pp. 2401-2411. https://doi.org/10.2337/db05-1635

Diabetic retinopathy : Seeing beyond glucose-induced microvascular disease. / Antonetti, David A.; Barber, Alistair J.; Bronson, Sarah K.; Freeman, Willard M.; Gardner, Thomas W.; Jefferson, Leonard S.; Kester, Mark; Kimball, Scot R.; Krady, J. Kyle; LaNoue, Kathryn F.; Norbury, Christopher C.; Quinn, Patrick G.; Sandirasegarane, Lakshman; Simpson, Ian A.

In: Diabetes, Vol. 55, No. 9, 01.09.2006, p. 2401-2411.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Diabetic retinopathy

T2 - Seeing beyond glucose-induced microvascular disease

AU - Antonetti, David A.

AU - Barber, Alistair J.

AU - Bronson, Sarah K.

AU - Freeman, Willard M.

AU - Gardner, Thomas W.

AU - Jefferson, Leonard S.

AU - Kester, Mark

AU - Kimball, Scot R.

AU - Krady, J. Kyle

AU - LaNoue, Kathryn F.

AU - Norbury, Christopher C.

AU - Quinn, Patrick G.

AU - Sandirasegarane, Lakshman

AU - Simpson, Ian A.

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Diabetic retinopathy remains a frightening prospect to patients and frustrates physicians. Destruction of damaged retina by photocoagulation remains the primary treatment nearly 50 years after its introduction. The diabetes pandemic requires new approaches to understand the pathophysiology and improve the detection, prevention, and treatment of retinopathy. This perspective considers how the unique anatomy and physiology of the retina may predispose it to the metabolic stresses of diabetes. The roles of neural retinal alterations and impaired retinal insulin action in the pathogenesis of early retinopathy and the mechanisms of vision loss are emphasized. Potential means to overcome limitations of current animal models and diagnostic testing are also presented with the goal of accelerating therapies to manage retinopathy in the face of ongoing diabetes.

AB - Diabetic retinopathy remains a frightening prospect to patients and frustrates physicians. Destruction of damaged retina by photocoagulation remains the primary treatment nearly 50 years after its introduction. The diabetes pandemic requires new approaches to understand the pathophysiology and improve the detection, prevention, and treatment of retinopathy. This perspective considers how the unique anatomy and physiology of the retina may predispose it to the metabolic stresses of diabetes. The roles of neural retinal alterations and impaired retinal insulin action in the pathogenesis of early retinopathy and the mechanisms of vision loss are emphasized. Potential means to overcome limitations of current animal models and diagnostic testing are also presented with the goal of accelerating therapies to manage retinopathy in the face of ongoing diabetes.

UR - http://www.scopus.com/inward/record.url?scp=33750597534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750597534&partnerID=8YFLogxK

U2 - 10.2337/db05-1635

DO - 10.2337/db05-1635

M3 - Review article

C2 - 16936187

AN - SCOPUS:33750597534

VL - 55

SP - 2401

EP - 2411

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 9

ER -